Reduced CD8+ T-cell infiltration of renal cell carcinoma (RCC)-derived pericytes and inhibition of cell proliferation and migration of endosialin (NE)-resistant pericytes can improve the efficacy of immune checkpoint blockade therapy for RCC [101]. This evidence concerns the gene CD248 and renal cell carcinoma.